NVACF:OTC-Nova Cannabis Inc (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 1.28

Change

-0.01 (-0.47)%

Market Cap

USD 0.08B

Volume

400.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Nova Cannabis Inc. operates retail cannabis stores with a focus on the recreational-use cannabis market in Canada. The company is headquartered in Edmonton, Canada. Nova Cannabis Inc. is a subsidiary of SNDL Inc.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
JDHIY JD Health International Inc

N/A

USD 10.21B
JDHIF JD Health International Inc

N/A

USD 9.97B
RADLY Raia Drogasil SA ADR

+0.20 (+4.35%)

USD 8.83B
ALBHF Alibaba Health Information Tec..

+0.01 (+2.17%)

USD 6.48B
CLCGY Clicks Group Ltd

-0.05 (-0.11%)

USD 5.41B
SAEYY Shop Apotheke Europe N.V

+1.66 (+13.24%)

USD 2.73B
SHPPF Shop Apotheke Europe N.V

N/A

USD 2.67B
ZRSEF Zur Rose Group AG

N/A

USD 0.68B
NOTR Nowtransit Inc

N/A

USD 0.55B
RXMD Progressive Care Inc

+0.16 (+9.21%)

USD 0.01B

ETFs Containing NVACF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 95.63% 88% B+ 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 95.63% 88% B+ 91% A-
Trailing 12 Months  
Capital Gain 150.98% 94% A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 150.98% 94% A 94% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.48% 37% F 43% F
Dividend Return 2.48% 37% F 39% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 76.36% 63% D 39% F
Risk Adjusted Return 3.25% 41% F 37% F
Market Capitalization 0.08B 61% D- 56% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.